Rozalyn L Rodwin
Overview
Explore the profile of Rozalyn L Rodwin including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
39
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kang L, Kadan-Lottick N, Rotatori J, Kujawski S, Messerschmidt E, Auerbach C, et al.
Semin Oncol Nurs
. 2024 Aug;
40(5):151716.
PMID: 39164160
Objectives: Childhood cancer survivors are at risk for chemotherapy-induced peripheral neuropathy (CIPN). Physical therapy (PT) improves CIPN symptoms, but little is known about survivors' PT utilization. We described characteristics of...
2.
Rodwin R, Wang F, Lu L, Li Z, Srivastava D, Phillips N, et al.
Cancer Med
. 2024 Jul;
13(14):e7422.
PMID: 39056576
Background: Survivors of childhood central nervous system (CNS) tumors can develop motor and sensory impairment from their cancer and treatment history. We estimated the prevalence of motor and sensory impairment...
3.
Rodwin R, DelRocco N, Hibbitts E, Devidas M, Whitley M, Mohrmann C, et al.
Pediatr Blood Cancer
. 2023 Aug;
70(11):e30634.
PMID: 37592363
Chemotherapy-induced peripheral neuropathy (CIPN), a common condition in children with acute lymphoblastic leukemia, can be challenging to diagnose. Using data from Children's Oncology Group AALL0932 physical function study, we sought...
4.
Graham C, Metayer C, Morimoto L, Wiemels J, Siddique A, Di M, et al.
Cancer Epidemiol Biomarkers Prev
. 2022 Jun;
31(9):1788-1795.
PMID: 35709749
Background: Hispanic ethnicity differences in the risk of early-onset Hodgkin lymphoma diagnosed at <40 years are understudied. We conducted a population-based case-control study to evaluate associations between birth characteristics and...
5.
Rodwin R, Kairalla J, Hibbitts E, Devidas M, Whitley M, Mohrmann C, et al.
J Natl Cancer Inst
. 2022 May;
114(8):1167-1175.
PMID: 35552709
Background: Children with B-acute lymphoblastic leukemia (B-ALL) are at risk for chemotherapy-induced peripheral neuropathy (CIPN). Children's Oncology Group AALL0932 randomized reduction in vincristine and dexamethasone (every 4 weeks vs 12...
6.
Physical Therapy Utilization Among Hospitalized Patients With Pediatric Acute Lymphoblastic Leukemia
Rodwin R, Ma X, Ness K, Kadan-Lottick N, Wang R
JCO Oncol Pract
. 2022 Apr;
18(7):e1060-e1068.
PMID: 35427182
Purpose: Patients with pediatric acute lymphoblastic leukemia (ALL) are at risk for impaired physical function from treatment. Early physical therapy (PT) may improve physical function and health in children with...
7.
Rodwin R, Siddiq N, Ehrlich B, Lustberg M
Front Pain Res (Lausanne)
. 2022 Apr;
3:864910.
PMID: 35360655
Chemotherapy induced peripheral neuropathy (CIPN) is an often severe and debilitating complication of multiple chemotherapeutic agents that can affect patients of all ages, across cancer diagnoses. CIPN can persist post-therapy,...
8.
Rodwin R, Janardan S, Hofstatter E, Kadan-Lottick N
J Pediatr Hematol Oncol
. 2022 Feb;
44(2):e585-e588.
PMID: 35200227
Childhood cancer survivors are at risk for subsequent neoplasms. We describe the clinical presentation and genetic testing of a 29-year-old woman diagnosed with a pheochromocytoma 22 years post-treatment for childhood...
9.
Kadan-Lottick N, Zheng D, Wang M, Bishop M, Srivastava D, Ross W, et al.
J Cancer Surviv
. 2022 Jan;
17(4):1238-1250.
PMID: 35059962
Purpose: Little is known regarding long-term neurocognitive outcomes in osteosarcoma and Ewing sarcoma (EWS) survivors despite potential risk factors. We evaluated associations among treatment exposures, chronic health conditions, and patient-reported...
10.
Rodwin R, Ross W, Rotatori J, Allen K, Auerbach C, Balsamo L, et al.
Pediatr Blood Cancer
. 2021 Dec;
69(3):e29550.
PMID: 34971076
Chemotherapy-induced peripheral neuropathy (CIPN), a debilitating side effect of pediatric cancer therapy, can be challenging to diagnose. We estimated the prevalence of newly identified and previously diagnosed CIPN in the...